Real-time Estimate
Cboe BZX
10:30:47 06/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
3.375
USD
|
-1.32%
|
|
+2.74%
|
+7.99%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
330.2
|
854.7
|
1,692
|
558
|
409.2
|
452.6
|
-
|
-
|
Enterprise Value (EV)
1 |
13,519
|
12,061
|
13,325
|
12,075
|
11,858
|
11,928
|
11,823
|
11,547
|
P/E ratio
|
-0.49
x
|
1.69
x
|
7.56
x
|
12.3
x
|
-3.07
x
|
-5.9
x
|
24.4
x
|
12.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.02
x
|
0.07
x
|
0.14
x
|
0.05
x
|
0.03
x
|
0.04
x
|
0.03
x
|
0.03
x
|
EV / Revenue
|
1.02
x
|
1.02
x
|
1.08
x
|
0.99
x
|
0.95
x
|
0.95
x
|
0.91
x
|
0.84
x
|
EV / EBITDA
|
8.3
x
|
6.67
x
|
6.77
x
|
8.24
x
|
8.16
x
|
7.7
x
|
7.24
x
|
6.63
x
|
EV / FCF
|
-255
x
|
6.94
x
|
-22.2
x
|
-105
x
|
-
|
87.7
x
|
72.1
x
|
-
|
FCF Yield
|
-0.39%
|
14.4%
|
-4.5%
|
-0.95%
|
-
|
1.14%
|
1.39%
|
-
|
Price to Book
|
-0.15
x
|
-0.59
x
|
-1.28
x
|
-0.43
x
|
-0.31
x
|
-0.37
x
|
-0.42
x
|
-0.53
x
|
Nbr of stocks (in thousands)
|
1,13,878
|
1,15,034
|
1,27,145
|
1,29,157
|
1,30,730
|
1,32,329
|
-
|
-
|
Reference price
2 |
2.900
|
7.430
|
13.31
|
4.320
|
3.130
|
3.420
|
3.420
|
3.420
|
Announcement Date
|
19/02/20
|
17/02/21
|
16/02/22
|
15/02/23
|
20/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
13,210
|
11,789
|
12,368
|
12,211
|
12,490
|
12,513
|
12,963
|
13,671
|
EBITDA
1 |
1,628
|
1,809
|
1,969
|
1,466
|
1,453
|
1,549
|
1,633
|
1,743
|
EBIT
1 |
1,020
|
1,251
|
1,429
|
932
|
948
|
1,058
|
1,122
|
1,208
|
Operating Margin
|
7.72%
|
10.61%
|
11.55%
|
7.63%
|
7.59%
|
8.46%
|
8.66%
|
8.84%
|
Earnings before Tax (EBT)
1 |
-430
|
422
|
499
|
349
|
207
|
176
|
284
|
-
|
Net income
1 |
-675
|
511
|
230
|
46
|
-133
|
-75.96
|
18.44
|
37.7
|
Net margin
|
-5.11%
|
4.33%
|
1.86%
|
0.38%
|
-1.06%
|
-0.61%
|
0.14%
|
0.28%
|
EPS
2 |
-5.930
|
4.390
|
1.760
|
0.3500
|
-1.020
|
-0.5800
|
0.1400
|
0.2800
|
Free Cash Flow
1 |
-53
|
1,738
|
-600
|
-115
|
-
|
136
|
164
|
-
|
FCF margin
|
-0.4%
|
14.74%
|
-4.85%
|
-0.94%
|
-
|
1.09%
|
1.27%
|
-
|
FCF Conversion (EBITDA)
|
-
|
96.08%
|
-
|
-
|
-
|
8.78%
|
10.04%
|
-
|
FCF Conversion (Net income)
|
-
|
340.12%
|
-
|
-
|
-
|
-
|
889.37%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19/02/20
|
17/02/21
|
16/02/22
|
15/02/23
|
20/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
3,233
|
3,111
|
2,934
|
3,025
|
3,142
|
3,108
|
3,115
|
3,086
|
3,181
|
3,140
|
3,090
|
3,066
|
3,221
|
3,236
|
3,211
|
EBITDA
1 |
540
|
409
|
253
|
400
|
404
|
335
|
373
|
360
|
386
|
378
|
378.4
|
368.5
|
424.8
|
396.2
|
395.1
|
EBIT
1 |
409
|
281
|
119
|
263
|
268
|
203
|
249
|
232
|
265
|
263
|
256.2
|
248.5
|
291.1
|
269.2
|
275.3
|
Operating Margin
|
12.65%
|
9.03%
|
4.06%
|
8.69%
|
8.53%
|
6.53%
|
7.99%
|
7.52%
|
8.33%
|
8.38%
|
8.29%
|
8.11%
|
9.04%
|
8.32%
|
8.57%
|
Earnings before Tax (EBT)
1 |
221
|
53
|
-98
|
70
|
325
|
6
|
40
|
-33
|
193
|
22
|
45
|
19
|
90
|
51
|
65
|
Net income
1 |
178
|
-1
|
-326
|
-42
|
414
|
-51
|
-38
|
-91
|
46
|
-41
|
-18.45
|
-23.5
|
7.489
|
-10.43
|
-0.668
|
Net margin
|
5.51%
|
-0.03%
|
-11.11%
|
-1.39%
|
13.18%
|
-1.64%
|
-1.22%
|
-2.95%
|
1.45%
|
-1.31%
|
-0.6%
|
-0.77%
|
0.23%
|
-0.32%
|
-0.02%
|
EPS
2 |
1.340
|
-0.0100
|
-2.520
|
-0.3200
|
3.180
|
-0.4000
|
-0.2900
|
-0.6900
|
0.3500
|
-0.3200
|
-0.1400
|
-0.1800
|
0.0550
|
-0.0750
|
-0.0100
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16/02/22
|
27/04/22
|
27/07/22
|
26/10/22
|
15/02/23
|
01/05/23
|
02/08/23
|
25/10/23
|
20/02/24
|
24/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
13,189
|
11,206
|
11,633
|
11,517
|
11,449
|
11,475
|
11,371
|
11,095
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
8.101
x
|
6.195
x
|
5.908
x
|
7.856
x
|
7.88
x
|
7.41
x
|
6.963
x
|
6.367
x
|
Free Cash Flow
1 |
-53
|
1,738
|
-600
|
-115
|
-
|
136
|
164
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-2.37%
|
3.23%
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
28,473
|
15,808
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-18.80
|
-12.50
|
-10.40
|
-10.10
|
-10.20
|
-9.220
|
-8.100
|
-6.450
|
Cash Flow per Share
|
3.380
|
18.60
|
-1.000
|
2.310
|
-
|
-
|
-
|
-
|
Capex
1 |
438
|
440
|
469
|
415
|
467
|
379
|
434
|
478
|
Capex / Sales
|
3.32%
|
3.73%
|
3.79%
|
3.4%
|
3.74%
|
3.03%
|
3.35%
|
3.5%
|
Announcement Date
|
19/02/20
|
17/02/21
|
16/02/22
|
15/02/23
|
20/02/24
|
-
|
-
|
-
|
Last Close Price
3.42
USD Average target price
4.394
USD Spread / Average Target +28.47% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.99% | 453M | | +13.83% | 80.61B | | -29.74% | 70.18B | | +11.76% | 29.12B | | -11.93% | 16.97B | | -0.71% | 16.96B | | -1.03% | 15.26B | | +4.35% | 12.41B | | -30.88% | 11.95B | | -4.59% | 11.93B |
Other Healthcare Facilities & Services
|